A Rare Case of Primary Carcinosarcoma of the Breast

Q4 Medicine Forum of Clinical Oncology Pub Date : 2023-03-27 DOI:10.2478/fco-2022-0006
M. Kiakou, M. Tolia, Nektarios Koufopoulos, K. Tsapakidis, E. Arvanitou, Gkikas Konstantinos, N. Charalambakis, Michalis Nikolaou, D. Matthaios, N. Tsoukalas
{"title":"A Rare Case of Primary Carcinosarcoma of the Breast","authors":"M. Kiakou, M. Tolia, Nektarios Koufopoulos, K. Tsapakidis, E. Arvanitou, Gkikas Konstantinos, N. Charalambakis, Michalis Nikolaou, D. Matthaios, N. Tsoukalas","doi":"10.2478/fco-2022-0006","DOIUrl":null,"url":null,"abstract":"Abstract Breast carcinosarcoma is a rare malignancy accounting for approximately 0.08–0.2% of all breast tumours. It is a type of metaplastic mammary carcinoma displaying biphasic differentiation with epithelial and mesenchymal cellular characteristics with probable derivation from myoepithelial cells. A 65-year-old woman presented to our hospital with a two-month history of a rapidly growing mass in her left breast. Neither her medical nor family history was positive for malignancies. Subsequently, she underwent a fine needle aspiration, which was positive for adenocarcinoma, followed by a lumpectomy with axillary lymph node dissection. The histology revealed an undifferentiated neoplasm and the immunohistochemical cell staining was positive for pan-cytokeratin, SMA, Vimentin, and S-100, suggesting the diagnosis of breast carcinosarcoma with a triple-negative immunophenotype. There was no evidence of metastasis except for a positive lymph node, indicating a stage IIIA disease. Thus, she received adjuvant chemo-radiotherapy. However, 16 months later, she presented with metastatic disease, and unfortunately, she died 4 months later due to a systemic infection. Aggressive behavior, higher staging, chemoresistance, and higher proportion of triple negative breast cancer seem to be the main characteristics of breast carcinosarcoma, which is recognised as a separate entity from common invasive ductal carcinoma, with significantly worse clinical outcomes.","PeriodicalId":38592,"journal":{"name":"Forum of Clinical Oncology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Forum of Clinical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/fco-2022-0006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Breast carcinosarcoma is a rare malignancy accounting for approximately 0.08–0.2% of all breast tumours. It is a type of metaplastic mammary carcinoma displaying biphasic differentiation with epithelial and mesenchymal cellular characteristics with probable derivation from myoepithelial cells. A 65-year-old woman presented to our hospital with a two-month history of a rapidly growing mass in her left breast. Neither her medical nor family history was positive for malignancies. Subsequently, she underwent a fine needle aspiration, which was positive for adenocarcinoma, followed by a lumpectomy with axillary lymph node dissection. The histology revealed an undifferentiated neoplasm and the immunohistochemical cell staining was positive for pan-cytokeratin, SMA, Vimentin, and S-100, suggesting the diagnosis of breast carcinosarcoma with a triple-negative immunophenotype. There was no evidence of metastasis except for a positive lymph node, indicating a stage IIIA disease. Thus, she received adjuvant chemo-radiotherapy. However, 16 months later, she presented with metastatic disease, and unfortunately, she died 4 months later due to a systemic infection. Aggressive behavior, higher staging, chemoresistance, and higher proportion of triple negative breast cancer seem to be the main characteristics of breast carcinosarcoma, which is recognised as a separate entity from common invasive ductal carcinoma, with significantly worse clinical outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一例罕见的原发性乳腺癌肉瘤
乳腺癌肉瘤是一种罕见的恶性肿瘤,约占所有乳腺肿瘤的0.08-0.2%。它是一种具有上皮细胞和间充质细胞特征的双期分化的乳腺化生癌,可能来源于肌上皮细胞。一名65岁女性,因左乳房快速生长的肿块两个月来就诊。她的病史和家族史都没有恶性肿瘤。随后,她接受了细针穿刺,腺癌阳性,随后进行了乳房肿瘤切除术并腋窝淋巴结清扫。组织学示未分化肿瘤,免疫组化细胞泛细胞角蛋白、SMA、Vimentin、S-100染色阳性,提示免疫表型为三阴性的乳腺癌肉瘤。除淋巴结阳性外,无转移迹象,提示为IIIA期疾病。因此,她接受了辅助化疗。然而,16个月后,她出现了转移性疾病,不幸的是,她在4个月后因全身感染而死亡。乳腺癌肉瘤具有侵袭性行为、分期高、耐药和三阴性乳腺癌比例高的特点,被认为是不同于普通浸润性导管癌的一个独立实体,其临床预后明显较差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Forum of Clinical Oncology
Forum of Clinical Oncology Medicine-Oncology
CiteScore
0.50
自引率
0.00%
发文量
3
审稿时长
6 weeks
期刊最新文献
Breast cancer recurrence and tumor size: A bibliometric analysis Outcomes of patients with localized prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy boost: A single-center retrospective study Glomerulonephritis as a paraneoplastic event from prostate cancer relapse Change of dosing paradigm in oncology Total neoadjuvant therapy in rectal cancer: a review across studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1